310 related articles for article (PubMed ID: 33868261)
1. Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lu S; Cai S; Peng X; Cheng R; Zhang Y
Front Immunol; 2021; 12():636614. PubMed ID: 33868261
[TBL] [Abstract][Full Text] [Related]
2. [Screening and identification of key genes ATP1B3 and ENAH in the progression of hepatocellular carcinoma: based on data mining and clinical validation].
Yang X; Li Y; Wu D; Ma Y; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):815-823. PubMed ID: 35790431
[TBL] [Abstract][Full Text] [Related]
3. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
5. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhang C; Wang H; Chen Z; Zhuang L; Xu L; Ning Z; Zhu Z; Wang P; Meng Z
Carcinogenesis; 2018 Apr; 39(4):562-570. PubMed ID: 29309535
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
Chen W; Ou M; Tang D; Dai Y; Du W
J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
[TBL] [Abstract][Full Text] [Related]
8. The clinical relevance of epithelial-mesenchymal transition and its correlations with tumorigenic immune infiltrates in hepatocellular carcinoma.
Qiu ZQ; Wang X; Ji XW; Jiang FJ; Han XY; Zhang WL; An YH
Immunology; 2022 Jun; 166(2):185-196. PubMed ID: 35274290
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.
Zhou T; Gao Y
World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762
[TBL] [Abstract][Full Text] [Related]
10. Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
Huang CJ; Zhang CY; Zhao YK; Wang D; Zhuang L; Qian L; Xie L; Zhu Y; Meng ZQ
Am J Chin Med; 2023; 51(2):461-485. PubMed ID: 36655687
[TBL] [Abstract][Full Text] [Related]
11. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma.
Wang H; Xu F; Yang F; Lv L; Jiang Y
Sci Rep; 2021 Jul; 11(1):14611. PubMed ID: 34272452
[TBL] [Abstract][Full Text] [Related]
14. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y
Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Zhang Y; Tang Y; Guo C; Li G
Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Prognostic Value, Immune Implication and Biological Function of
Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
Front Immunol; 2021; 12():723293. PubMed ID: 34899687
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
19. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
20. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]